Limitations, agreements, and source contact

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery · Source last updated 2026-02-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

LTE60

restrictive Agreement

true

limitations And Caveats

description

Based on negative results from trial NCT00634725 regarding the question of gemcitabine versus gemcitabine plus erlotinib in locally unresectable pancreatic cancer patients, this study was amended to stop the erlotinib randomization and to change the erlotinib question to a randomized phase II design using the patients already randomized.

point Of Contact

email

seiferheldw@nrgoncology.org

organization

NRG Oncology

phone

2155743208

title

Wendy Seiferheld

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice